Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
09/2004
09/15/2004EP1456173A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
09/15/2004EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors
09/15/2004EP1456171A1 Substituted cyclohexane derivatives
09/15/2004EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
09/15/2004EP1088825B9 Enantiomerically pure substituted oxaaza compounds, salts of the same, and processes for the preparation of both
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/15/2004EP0775689B9 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic
09/15/2004EP0710109B1 Method for identifying a PDE IV inhibitor
09/15/2004EP0693072B9 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes
09/15/2004CN1529593A 2-pyrrolidone derivatives as prostanoid agonists
09/15/2004CN1528746A Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method
09/15/2004CN1528745A Pyrrolidine matrix metall oprotease inhibitor and preparing method thereof
09/15/2004CN1528744A Positron emitted computerized tomography imaging agent benzamide derivative synthesizing method
09/15/2004CN1166699C Recovery of modifier compounds and polar organic compounds from a poly (arylene sulfide)
09/15/2004CN1166654C Benzoylguanidine derivatives wit advantageous properties, method for producing them and their use in production of medicaments
09/15/2004CN1166635C Trifuoro methylpyrrol carboxamides
09/15/2004CN1166634C 15N-proline separating and purifying meethod
09/15/2004CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
09/15/2004CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same
09/15/2004CN1166614C Indandione compounds and its preparing process and application
09/14/2004US6790860 Pyrrolidine derivatives
09/14/2004US6790597 Rapid cure, stable to elevated temperatures, are highly flexible, have low moisture uptake
09/14/2004CA2280708C Cetp activity inhibitors
09/14/2004CA2103110C Insecticidal n'-substituted-n,n'-diacylhydrazines
09/10/2004WO2004076416A1 Method of obtaining an antiepileptic agent
09/10/2004WO2004076415A1 1- (hetero)aroyl-pyrrolidine-2-carboxylic acid derivatives useful as anti.viral agents
09/10/2004WO2004076407A2 Pyrrolidine derivatives as oxytocin antagonists
09/10/2004WO2004076388A2 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
09/10/2004WO2004075847A2 METHODS AND COMPOUNDS FOR THE TREATMENT OF Aß­ ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS
09/10/2004WO2004056755A3 Compounds for the inhibition of non-proteolytic enzymes
09/10/2004WO2004056727A8 Process of making chalcone derivatives
09/10/2004WO2004041211A3 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT
09/10/2004WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives
09/10/2004WO2004007445A3 Protein kinase c modulators, and methods of use thereof
09/10/2004WO2004007444A3 N-hydroxyamide derivatives possessing antibacterial activity
09/10/2004WO2003079984A3 Substituted tetracycline compounds
09/10/2004CA2515801A1 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
09/09/2004US20040176615 Forming calcium salt from ester
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176589 Processing a dicarbonyl compound to form cyclic compound reaction with alkylation
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
09/09/2004US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors
09/09/2004US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
09/09/2004US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease;
09/09/2004US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants
09/09/2004DE10307725A1 Korrosions-und Gashydratinhibitoren mit verbesserter Wasserlöslichkeit und erhöhter biologischer Abbaubarkeit Corrosion and gas hydrate inhibitors with improved water solubility and increased biodegradability
09/09/2004DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments
09/08/2004EP1453792A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
09/08/2004EP1453790A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1453503A2 Ep4 receptor agonist, compositions and methods thereof
09/08/2004EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
09/08/2004EP1289972B1 Serine protease inhibitors
09/08/2004EP1289950B1 Serine protease inhibitors
09/08/2004EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
09/08/2004EP1084119B1 Aromatic amine derivatives as pharmaceutical agents
09/08/2004EP0944581A4 Process of preparing substituted acrylamides
09/08/2004EP0763009B1 Photocleavable conjugates for the detection and isolation of biomolecules
09/08/2004CN1527876A Compounds, compositions, and methods for controlling biofilms
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/07/2004US6787564 For treating hypoxia protective, nootropic and neurodegenerative diseases (cerbral ischemia, alzheimer's disease, and vascular dementia)
09/07/2004US6787563 Antidiarrhea agents; gastrointestinal disorders
09/07/2004US6787540 Compounds useful as reversible inhibitors of cysteine proteases
09/07/2004US6787522 Antibacterial agents
09/07/2004CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases
09/07/2004CA2093770C Aspartic acid derivatives, their preparation and use
09/02/2004WO2004074256A1 Tetrahydroisoquinolinyl sulfamic acids
09/02/2004WO2004074250A1 Novel compounds and compositions containing the same
09/02/2004WO2004074238A1 Phenethylamino sulfamic acids
09/02/2004WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/02/2004WO2004073606A2 Sulfonamide derivatives as ppar modulators
09/02/2004WO2004073598A2 Solid phase synthesis of antitumoral compounds
09/02/2004WO2004073585A2 Methode of manufacturing glimepiride and the respective intermediate
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171860 Novel acylating reagents
09/02/2004US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
09/02/2004US20040171845 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
09/02/2004US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS
09/02/2004US20040171670 Neurological diseases and disorders; such as 3-fluoro-10,11-dihydro-5-(2-aminoethyl)-5H-dibenzo[a,d]cycloheptene
09/02/2004US20040171655 Active against cancer proliferation, growth, and metastasis; such as 3,4,5-trimethoxy-n-(2-methyl-3-phenyl-allyl)-n-[2-(1-methyl-pyrrolidin-2-yl)-thyl]-benzamide; side effect reduction
09/02/2004US20040171642 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia
09/02/2004US20040171639 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
09/02/2004US20040171614 Novel gamma secretase inhibitors
09/02/2004US20040171608 Synthesis of clasto-lactacystin beta-lactone and analogs thereof
09/02/2004US20040171520 Melanocortin receptor-specific peptidomimetics
09/02/2004US20040171490 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture
09/02/2004US20040170890 novel 2,2,2-trifluoro-N-(trifluoromethanesulfonyl) acetamide*tetraethyl ammonium salt
09/02/2004US20040170634 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
09/02/2004DE3844978B4 New tri:phenyl-cerium cpd.
09/02/2004CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/02/2004CA2515520A1 Methode of manufacturing glimepiride and the respective intermediate
09/02/2004CA2515313A1 Solid phase synthesis of antitumoral compounds
09/02/2004CA2512883A1 Sulfonamide derivatives as ppar modulators
09/01/2004EP1453087A1 Microelectronic assembly
09/01/2004EP1452534A1 Pleuromutlin derivatives as antimicrobials
09/01/2004EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses"
09/01/2004EP1452522A2 Novel compounds and compositions as protease inhibitors
09/01/2004EP1451195A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
09/01/2004EP1451179A1 Pyrrole synthesis